Lantern was a mental health startup that offered an app for self-evaluation and daily exercises to help users restructure negative thoughts. Despite raising $17 million and gaining initial traction, it shut down in 2018 due to failed acquisition deals and a challenging business model. Its technology now lives on through Spring Health.
Lantern's main product was a behavioral health app offering self-evaluation assessments and daily exercises to help users restructure negative thoughts. Its unique value proposition included access to behavioral change coaches and a focus on meditation and mindfulness. Notably, Lantern raised $17 million in Series A funding and its technology now enhances Spring Health's platform.
The story of Lantern's rise and fall is a compelling narrative of initial success, strategic missteps, and eventual decline:
Lantern shut down its commercial operations effective August 1, 2018. Despite initial success and substantial funding, the company faced significant challenges, including failed acquisition deals and difficulties aligning with traditional healthcare insurance companies.
Lantern faced significant setbacks when several acquisition deals fell through, leading to its decision to shut down operations. Despite initial interest, potential buyers backed out, leaving Lantern without the necessary financial support to continue. This failure to secure a buyer was a critical blow to the company's survival.
Lantern's CEO, Alejandro Foung, admitted that the company misjudged the time required to achieve sustainable revenue through traditional healthcare insurance companies. The slow pace of the healthcare industry made it difficult for Lantern to align its innovative app with existing reimbursement models, ultimately stalling its growth.
The absence of a reimbursement model for behavioral health services was a significant challenge for Lantern. Without a clear path to insurance reimbursement, the company struggled to generate consistent revenue. This issue was compounded by the high costs associated with sidestepping FDA regulations.
Lantern faced difficulties in recruiting trained clinicians with experience in behavioral health. This challenge hindered the company's ability to scale its services effectively. The shortage of qualified professionals limited Lantern's capacity to meet the growing demand for mental health support.
Attempting to sidestep FDA regulations by going directly to employers and consumers proved to be an expensive mistake for Lantern. The high operational costs associated with this strategy drained resources and made it difficult for the company to maintain financial stability.
Lantern's story is a stark reminder of how quickly a promising startup can face insurmountable challenges. If you're in a similar situation, book a demo with Sunset to see how we can help you navigate the complexities of winding down your business.
Sunset takes care of all the legal, tax, and operational burdens, allowing you to avoid penalties and reduce liabilities. Let us handle the tough parts so you can move on to your next venture with peace of mind.